Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 39Carcinoma, Ovarian Epithelial 20Testicular Neoplasms 16Sarcoma 15Testicular Germ Cell Tumor 12Neuroectodermal Tumors, Primitive, Peripheral 9Fallopian Tube Neoplasms 9Central Nervous System Neoplasms 8Teratoma 7Neuroblastoma 7Kidney Neoplasms 7Wilms Tumor 6Endometrial Neoplasms 6Uterine Cervical Neoplasms 5Ovarian Germ Cell Cancer 5Osteosarcoma 5Endodermal Sinus Tumor 5Seminoma 4Retinoblastoma 4Medulloblastoma 4Head and Neck Neoplasms 4Fibrosarcoma 4Chondrosarcoma 4Carcinoma, Embryonal 4Breast Neoplasms 4Astrocytoma 4Optic Nerve Glioma 3Neoplasms 3Melanoma 3Malignant mesenchymal tumor 3

Interventions

pegfilgrastim 1Paclitaxel 1Filgrastim 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Adenosquamous Carcinoma × Filgrastim × Gynecologic × Clear all
NCT00575952 2017-08-24

Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer

GOG Foundation

Phase 1 Completed
27 enrolled
Gynecologic

Endometrial Adenosquamous Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡